Is Ginkgo Bioworks (DNA) a good stock to buy?

Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts. [Read more] In 2022, DNA's revenue was $477.71 million, an increase of 52.21% compared to the previous year's $313.84 million. Losses were -$2.10 billion, 15.0% more than in 2021. According to 4 analysts, the average rating for DNA stock is "Sell."

What does Ginkgo Bioworks stand for?

BOSTON , Sept. 6, 2023 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, announced today that Anna Mari...

Is Ginkgo Bioworks partnering with Google Cloud?

Jason Kelly, Ginkgo Bioworks CEO, joins 'Closing Bell Overtime' to talk partnering with Google Cloud, its AI offerings and more. Get a real-time Ginkgo Bioworks Holdings, Inc. (DNA) stock price quote with breaking news, financials, statistics, charts and more.

What is Ginkgo Bioworks holdings ISS governance qualityscore?

Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts. Ginkgo Bioworks Holdings, Inc.’s ISS Governance QualityScore as of December 1, 2023 is 10. The pillar scores are Audit: 9; Board: 6; Shareholder Rights: 10; Compensation: 9.